As research advances and real-world experience accumulates, the integration of these agents into multifaceted, patient-centered care models holds promise for reshaping the future of weight management
Frederiksen TM, Snderby P, Ryberg LA, et al
Provider Review A licensed Pennsylvania provider reviews your health history and weight loss goals
Supplement recommendations for GLP-1 users apply equally to retatrutide, since the appetite suppression mechanisms are similar across the class
The Wegovy pill (25 mg) produces an average weight loss of 13.6% in 64 weeks (about a year and three months), according to a study of adults with obesity or overweight
Texas law permits telehealth prescribing of non-controlled medications, including GLP-1 receptor agonists, after a single real-time audio-video visit